Area of research
Pulmonary and Respiratory Medicine · Hepatology
Research interest
Research interests include Medicine, Internal medicine, Cystic fibrosis, Primary ciliary dyskinesia, Ivacaftor, and Placebo.
Impact of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance and Abnormal Glucose Metabolism: A Phase 3b, Open-Label Clinical Trial
International consensus statement on routine blood testing in primary ciliary dyskinesia
Associations between respiratory pathogens and lung function in primary ciliary dyskinesia: cross-sectional analysis from the PROVALF-PCD cohort
Phase 3 Open-Label Clinical Trial of Elexacaftor/Tezacaftor/Ivacaftor in Children Aged 2–5 Years with Cystic Fibrosis and at Least One <i>F508del</i> Allele
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trial
International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives
Cutaneous adverse events: a predictor of tumour response under anti‐<scp>PD</scp>‐1 therapy for metastatic melanoma, a cohort analysis of 189 patients
Left ventricular ejection fraction decrease related to BRAF and/or MEK inhibitors in metastatic melanoma patients: A retrospective analysis
Pulmonary exacerbations in patients with primary ciliary dyskinesia: an expert consensus definition for use in clinical trials
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma
<p>Medication adherence in pediatric transplantation and assessment methods: a systematic review</p>
Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients
Prevalence, Risk Factors, and Impact of Donor‐Specific Alloantibodies After Adult Liver Transplantation
Biomechanical Characterization of Intracranial Aneurysm Wall: A Multiscale Study
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial
The effect of pre‐operative gastric ultrasound examination on the choice of general anaesthetic induction technique for non‐elective paediatric surgery. A prospective cohort study
Comparative effectiveness of recommended versus less intensive drug combinations in secondary prevention of acute coronary syndrome
RENAL DEVELOPMENT AND CYSTIC DISEASES
Prophylactic use of sublingual allergen immunotherapy in high-risk children: A pilot study
Pooled analysis of two large randomised phase III inhaled mannitol studies in cystic fibrosis
Shared<i>Pseudomonas aeruginosa</i>genotypes are common in Australian cystic fibrosis centres
Clarithromycin therapy for patients with Cystic Fibrosis: A randomized controlled trial